Mesoporous silicon nanotechnology for cancer applications;Les nanoparticules de silice mésoporeuse pour combattre le cancer

Bio Tribune Magazine

Volumn 33, Issue 1, 2009, Pages 21-24

  Bouamrani, A ^a   Serda, R E ^a   Ferrari, M ^a,b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Rice University   (United States)

Author keywords

Drug delivery; Personalized medicine; Proteomics; Silicon

Indexed keywords

EID: 77954262380     PISSN: 17729416     EISSN: 1951655X     Source Type: Journal    
DOI: 10.1007/s11834-009-0132-3     Document Type: Article

References (24)

1. Brown PO, Hartwell L (1998) Genomics and human disease-variations on variation. Nat Genet 18: 91-93.
2. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E (2006) Cancer biomarkers: A systems approach. Nat Biotechnol 24: 905-908.
3. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J (1998) Recombinant humanized anti-her2 antibody (herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against her2/neu over-expressing human breast cancer xenografts. Cancer Res 58: 2825-2831.
4. Ward HW (1973) Anti-oestrogen therapy for breast cancer: A trial of tamoxifen at two dose levels. Br Med J 1: 13-14.
5. Plourde PV, Dyroff M, Dukes M (1994) Arimidex: A potent and selective fourth-generation aromatase inhibitor. Breast Cancer Res Treat 30: 103-111.
6. Tasciotti E, Liu X, Bhavane R, Plant K, Leonard AD, Price BK, Cheng MM, Decuzzi P, Tour JM, Robertson F, Ferrari M (2008) Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 3: 151-157.
7. Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, Ferrari M (2009) The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 30: 2440-2448.
8. Chiappini C, Fakhoury JR, Fine D, Pullan L, Wang Y, Fu L, Ferrari M (2009) Tailored porous silicon microparticles for the delivery of nanoparticles. Advanced Materials (submitted).
9. Decuzzi P, Ferrari M (2008) Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 29: 377-384.
10. Ruoslahti E (2004) Vascular zip codes in angiogenesis and metastasis. Biochem Soc Trans 32: 397-402.
11. Serda RE, Gu J, Burks JK, Ferrari C, Ferrari K, Ferrari M (2009) Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry Part A 75A: 752-760.
12. Serda RE, Ferrati S, Godin B, Tasciotti E, Liu X, Ferrari M (2009) Mitotic partitioning of silicon microparticles. Nanoscale (submitted).
13. Serda RE, Mack A, Pulikkathara M, Chiappini C, Zaske AM, Conyers JL, Bakson JA, Liu X, Ferrari M (2009) Cellular association and assembly of a multistage delivery system for magnetic resonance imaging (submitted).
14. Nickoloff JA (1992) Transcription enhances intrachromosomal homologous recombination in mammalian cells. Mol Cell Biol 12: 5311-5318.
15. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422: 198-207.
16. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L (2003) The case for early detection. Nat Rev Cancer 3: 243-252.
17. Liotta LA, Ferrari M, Petricoin E (2003) Clinical proteomics: Written in blood. Nature 425: 905.
18. Anderson NL, Anderson NG (2002) The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
19. Diamandis EP (2004) Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: Opportunities and potential limitations. Mol Cell Proteomics 3: 367-378.
20. Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ, Tempst P (2005) Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 4: 1060-1072.
21. Ferrari M (2005) Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 5: 161-171.
22. Gaspari M, Cheng MMC, Terracciano R, Liu XW, Nijdam AJ, Vaccari L, di Fabrizio E, Petricoin EF, Liotta LA, Cuda G, Venuta S, Ferrari M (2006) Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma. Journal of Proteome Research 5: 1261-1266.
23. Terracciano R, Gaspari M, Testa F, Pasqua L, Tagliaferri P, Cheng MM, Nijdam AJ, Petricoin EF, Liotta LA, Cuda G, Ferrari M, Venuta S (2006) Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles. Proteomics 6: 3243-3250.
24. Findeisen P, Sismanidis D, Riedl M, Costina V, Neumaier M (2005) Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 51: 2409-2411.